Mantle Cell Lymphoma (1)

Refractory Mantle Cell Lymphoma (MCL) (1)

Relapsed Mantle Cell Lymphoma (1)

Not yet recruiting (1)

phase 2 (1)

BeiGene (1)

bgb-11417 (1)

drug (1)

Industry (1)

Interventional (1)

refractory mantle cell lymphoma (mcl)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Jul 25, 2022